Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JenKem Technology is a global leader in the manufacture of high-purity polyethylene glycol derivatives and related custom synthesis services. Its products are used in over 20 commercial drugs, vaccines, medical devices, and more than 80 innovative projects worldwide across all clinical stages as of 2024[1][2]. The company holds over 100 active patents related to PEG technologies[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JenKem Technology.